Literature DB >> 8404924

Isolation of Campylobacter jejuni strains resistant to nalidixic acid and fluoroquinolones from children with diarrhea in Athens, Greece.

S Chatzipanagiotou, E Papavasiliou, E Malamou-Lada.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 8404924     DOI： 10.1007/bf01970969

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN： 0934-9723            Impact factor:   3.267


× No keyword cloud information.
  8 in total

1.  Characterization of high-level quinolone resistance in Campylobacter jejuni.

Authors:  T D Gootz; B A Martin
Journal:  Antimicrob Agents Chemother       Date:  1991-05       Impact factor: 5.191

2.  Fluoroquinolone-resistance in thermophilic Campylobacter spp isolated from stools of Spanish patients.

Authors:  J Reina; P Alomar
Journal:  Lancet       Date:  1990-07-21       Impact factor: 79.321

3.  Fluoroquinolone resistance in Campylobacter spp isolated from human stools and poultry products.

Authors:  H P Endtz; R P Mouton; T van der Reyden; G J Ruijs; M Biever; B van Klingeren
Journal:  Lancet       Date:  1990-03-31       Impact factor: 79.321

4.  Emergence of fluoroquinolone resistance in Campylobacter jejuni and Campylobacter coli in subjects from Finland.

Authors:  H Rautelin; O V Renkonen; T U Kosunen
Journal:  Antimicrob Agents Chemother       Date:  1991-10       Impact factor: 5.191

5.  Comparative in vitro activity of ciprofloxacin against Campylobacter spp. and other bacterial enteric pathogens.

Authors:  L J Goodman; R M Fliegelman; G M Trenholme; R L Kaplan
Journal:  Antimicrob Agents Chemother       Date:  1984-04       Impact factor: 5.191

6.  A demographic survey of campylobacter, salmonella and shigella infections in England. A Public Health Laboratory Service Survey.

Authors:  M B Skirrow
Journal:  Epidemiol Infect       Date:  1987-12       Impact factor: 2.451

7.  High-level quinolone resistance in clinical isolates of Campylobacter jejuni.

Authors:  J Segreti; T D Gootz; L J Goodman; G W Parkhurst; J P Quinn; B A Martin; G M Trenholme
Journal:  J Infect Dis       Date:  1992-04       Impact factor: 5.226

8.  Urease-positive thermophilic Campylobacter (Campylobacter laridis variant) isolated from an appendix and from human feces.

Authors:  F Mégraud; D Chevrier; N Desplaces; A Sedallian; J L Guesdon
Journal:  J Clin Microbiol       Date:  1988-05       Impact factor: 5.948
  8 in total
  3 in total

1.  Quinolone and macrolide resistance in Campylobacter jejuni and C. coli: resistance mechanisms and trends in human isolates.

Authors:  J Engberg; F M Aarestrup; D E Taylor; P Gerner-Smidt; I Nachamkin
Journal:  Emerg Infect Dis       Date:  2001 Jan-Feb       Impact factor: 6.883

Review 2.  Fluoroquinolones in paediatrics--1995.

Authors:  R Dagan
Journal:  Drugs       Date:  1995       Impact factor: 9.546

Review 3.  Ciprofloxacin. An updated review of its pharmacology, therapeutic efficacy and tolerability.

Authors:  R Davis; A Markham; J A Balfour
Journal:  Drugs       Date:  1996-06       Impact factor: 9.546
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.